State Laws and Generic Substitution in the Year After New Generic Competition.

Rome, Benjamin N; Sarpatwari, Ameet; Kesselheim, Aaron S

Rome, Benjamin N; Sarpatwari, Ameet; Kesselheim, Aaron S.

Afiliação

Rome BN; Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. Electronic address: brome@bwh.harvard.edu.
Sarpatwari A; Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
Kesselheim AS; Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.

Value Health ; 25(10): 1736-1742, 2022 10.

Article em En | MEDLINE | ID: mdl-35487821

Assuntos

Medicamentos Genéricos; Medicamentos sob Prescrição; Idoso; Substituição de Medicamentos; Medicamentos Genéricos/uso terapêutico; Humanos; Medicare; Farmacêuticos; Estados Unidos

Palavras-chave

brand name drugs; generic drugs; generic substitution; prescription drugs; state health policy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Medicamentos Genéricos / Medicamentos sob Prescrição Limite: Aged / Humans País/Região como assunto: America do norte Idioma: En Revista: Value Health Assunto da revista: FARMACOLOGIA Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google